查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018605

乾血斑採集卡市場：2026-2030年全球市場預測（依產品類型、技術、檢體類型、應用、最終用戶及通路分類）

Dried Blood Spot Collection Cards Market by Product Type, Technology, Sample Type, Application, End User, Distribution Channel - Global Forecast 2026-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年乾血斑採集卡的市場規模為 3.8431 億美元，預計到 2025 年將成長至 4.0541 億美元，複合年成長率為 5.59%，到 2030 年將達到 5.3283 億美元。

主要市場統計數據
基準年 2024 3.8431億美元
預計年份：2025年 4.0541億美元
預測年份 2030 5.3283億美元
複合年成長率 (%) 5.59%

探索乾血斑採集卡在現代醫療保健服務、遠距醫療和診斷技術創新中日益重要的作用和多方面的優勢。

乾血斑採集卡正逐漸成為醫療領域的創新工具，它簡化了檢體的收集和儲存流程，同時保持了分析的準確性。隨著分散式檢查需求的不斷成長，這些採集卡能夠安全且有效率地將檢體從偏遠地區的患者運送至中心檢查室。由於其生物風險極低，且在各種環境條件下性能穩定，乾血斑採集卡在臨床檢體採集和先進診斷平台之間發揮至關重要的橋樑作用。

分析了改變臨床和研究應用中乾血斑採集卡格局的變革性創新和技術進步。

材料科學和分析化學領域的最新突破引發了乾血斑卡領域的模式轉移。改良後的卡片基材採用聚合物塗層，可增強分析物的保存效果，降低血球比容的影響，並縮短乾燥時間。這些創新使得生物標記的回收率更加穩定，從而支持藥物動力學研究和疾病篩檢計畫中日益複雜的檢測方法。

評估美國徵收關稅對乾血斑採集卡的供應鏈、成本結構和戰略應對的累積影響。

美國2025年實施的新關稅表對乾血斑採集卡產業的供應鏈物流和成本結構產生了重大影響。對專用紙基材和聚合物試劑徵收的進口關稅迫使製造商重新評估其籌資策略，並正在探索與替代供應商談判以及近岸外包的機會，以減輕不斷變化的貿易政策的影響。

將 DBS 卡市場按產品類型、技術、檢體變化、應用領域、最終用戶和分銷管道進行關鍵市場細分分析。

對乾血斑 (DBS) 採集卡市場的分析表明，產品類型的差異顯著影響使用者的選擇標準。終端用戶在比較紙質濾卡和聚合物塗層卡時，優先考慮分析物穩定性、檢體均一性以及與下游檢測方法的兼容性等特性。同時，標準 DBS 卡和專為高通量應用和提高生物標記回收率而設計的高級 DBS 卡之間存在明顯的技術差異。

說明美洲、歐洲、中東和非洲以及亞太地區乾血斑採集卡的關鍵區域趨勢和策略成長要素。

幹血斑採集卡市場的區域趨勢反映了不同地區醫療基礎設施和法律規範的差異。在美洲，完善的診斷檢測網路、寬鬆的報銷政策以及聯邦政府對公共衛生監測舉措的支持，正推動著乾血斑採集卡的廣泛應用。該地區的市場參與企業正利用戰略夥伴關係關係，拓展遠端採樣項目，並簡化跨越廣闊地域的檢體運輸流程。

分析推動乾血斑採集卡產業創新、夥伴關係策略和競爭地位的關鍵產業參與者。

乾血斑 (DBS) 採集卡的競爭格局既包括成熟的生命科學公司，也包括專注於特定領域的專業企業。主要企業正利用其在基質技術方面的長期積累，推出能夠滿足關鍵性能參數要求的下一代卡片。這些企業通常與檢測開發人員和儀器製造商建立策略合作夥伴關係，以檢驗其產品在不同應用中的有效性。

為行業領導者提供可操作的策略建議，以利用星展銀行卡市場的新機會並應對不斷變化的挑戰。

為在瞬息萬變的乾血斑 (DBS) 採集卡市場取得成功，產業領導者應優先考慮材料創新，投入資源研發先進聚合物和基材，以提高在各種環境條件下的分析物回收率。同時，整合數位化追蹤功能至關重要，它能確保樣本可追溯性，增強資料完整性，並滿足日益嚴格的監管要求。

本文詳細介紹了構成本次 DBS 血液採集卡調查基礎的綜合調查方法、資料收集方法和分析架構。

本研究採用多層次調查方法，以確保研究的深度、準確性和相關性。基礎層包括廣泛的二手資料研究，例如行業出版物、監管指南和同行評審期刊，以確定材料創新的範圍、應用領域和競爭趨勢。這些桌上研究被用來編製結構化訪談指引和問卷。

這個結論總結了影響乾血斑採集卡未來發展的關鍵趨勢、市場動態和新興挑戰。

總而言之，幹血斑採集卡正處於現代診斷領域創新與普及的交會點。材料技術和數位化整合的進步正在重新定義性能標準，而監管協調的努力則正在加強全球市場的品質保證。關稅導致的供應鏈重組凸顯了策略採購和本地生產能力的重要性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：乾血斑採集卡市場：依產品類型分類

  • 濾紙卡
  • 聚合物塗層卡片

第9章：幹血斑採集卡市場：依技術分類

  • 高級DBS卡
  • 標準星展卡

第10章：依檢體類型分類的乾血斑採集卡市場

  • 等離子斑點
  • 血清斑點
  • 全血斑點

第11章：幹血斑採集卡市場：依應用領域分類

  • 臨床診斷
  • 疾病監測
  • 法醫學毒理學
  • 新生兒篩檢
    • 先天性甲狀腺機能低下症
    • 囊腫纖維化篩檢
    • 苯酮尿症
  • 藥物監測

第12章：幹血斑採集卡市場：依最終用戶分類

  • 診斷檢查室
  • 居家照護設施
  • 醫院和診所
  • 研究機構

第13章：幹血斑採集卡市場：依通路分類

  • 直銷
  • 銷售代理商和批發商

第14章：幹血斑採集卡市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：幹血斑採集卡市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：各國幹血斑採集卡市場概況

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國乾血斑採集卡市場

第18章：中國乾血斑採集卡市場

第19章 競爭情勢

  • 2024年市場集中度分析
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2024 年
  • 2024年產品系列分析
  • 基準分析，2024 年
  • ADVANTEC MFS, INC.
  • Ahlstrom Oyj
  • ARCHIMEDlife GmbH by amedes Holding GmbH
  • BioIVT LLC
  • Cambrian Biotech Pvt. Ltd.
  • Capitainer AB
  • CENTOGENE GmbH
  • Chemie-Erzeugnisse und Adsorptionstechnik AG
  • DBS System SA
  • Eastern Business Forms, Inc
  • F. Hoffmann-La Roche Ltd.
  • Huachenyang（Shenzhen）Technology Co., Ltd
  • Inotiv, Inc.
  • Kala Scientific INC.
  • Merck KGaA
  • Monobind Inc.
  • OmegaQuant Analytics, LLC
  • QIAGEN NV
  • RDA Spot Inc
  • Salimetrics, LLC.
  • Shimadzu Corporation
  • Telimmune LLC
  • Tianjin Geneally Biotechnology Co., Ltd.
Product Code: MRR-2214614766F5

The Dried Blood Spot Collection Cards Market was valued at USD 384.31 million in 2024 and is projected to grow to USD 405.41 million in 2025, with a CAGR of 5.59%, reaching USD 532.83 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 384.31 million
Estimated Year [2025] USD 405.41 million
Forecast Year [2030] USD 532.83 million
CAGR (%) 5.59%

Exploring the evolving significance and multifaceted benefits of dried blood spot collection cards in modern healthcare delivery, remote testing, and diagnostic innovation

Dried blood spot collection cards have emerged as a transformative tool in healthcare, offering simplified sample collection and storage while maintaining analytical accuracy. As the demand for decentralized testing continues to rise, these cards facilitate the safe and efficient transport of specimens from remote patient locations to central laboratories. With minimal biohazard risk and extended stability under varied environmental conditions, they serve as a vital bridge between point-of-care sampling and advanced diagnostic platforms.

In recent years, the versatility of dried blood spot collection cards has extended across clinical diagnostics, therapeutic monitoring, and epidemiological surveillance. Their low-volume sampling requirements reduce patient discomfort and logistical constraints inherent to venous draws. Meanwhile, technological enhancements in filter paper matrices and polymer coatings have improved analyte recovery and assay compatibility. As you delve further into this executive summary, the convergence of these factors will reveal why dried blood spot collection cards are rapidly gaining prominence as a cost-effective and scalable solution for modern laboratory workflows.

Analyzing transformative innovations and technological advancements reshaping the dried blood spot collection card landscape across clinical and research applications

Recent breakthroughs in material science and analytical chemistry have initiated a paradigm shift in the dried blood spot card arena. Enhanced card substrates now integrate polymer coatings that bolster analyte preservation, mitigate hematocrit effects, and accelerate drying times. These innovations enable more consistent recovery of biomarkers, supporting increasingly sophisticated assays used in pharmacokinetic studies and disease screening programs.

Simultaneously, the integration of digital technologies and connectivity features in collection cards is transforming data integrity and traceability. Embedded identifiers and interactive modules facilitate real-time sample tracking from point of collection to result reporting. As regulators worldwide emphasize stringent chain-of-custody protocols and quality assurance frameworks, these technological advancements ensure compliance while optimizing laboratory throughput.

Consequently, stakeholders across the value chain-from sample collectors to diagnostic laboratories-are redefining standard operating procedures to leverage these disruptive developments. By closely monitoring material innovations and regulatory alignments, manufacturers and end users can position themselves at the forefront of this rapidly evolving landscape.

Assessing the cumulative effects of United States tariff implementations on dried blood spot collection card supply chains, cost structures, and strategic responses

The introduction of new tariff schedules in the United States for 2025 has had a pronounced influence on supply chain logistics and cost structures within the dried blood spot collection card sector. Import duties imposed on specialized paper substrates and polymer reagents drove manufacturers to reassess procurement strategies, prompting negotiations with alternative suppliers and the exploration of nearshoring opportunities to mitigate exposure to fluctuating trade policies.

In response, several organizations have diversified their raw material sources and invested in local production capabilities to reduce lead times and buffer against potential duty escalations. While these strategic shifts initially increased capital expenditure, they ultimately strengthened supply chain resilience and reduced vulnerability to geopolitical shifts. Moreover, streamlined supplier agreements enhanced transparency in cost allocations, allowing for more predictable pricing models and long-term contract negotiations with diagnostic laboratories and research institutes across the nation.

As the industry continues to adapt to evolving tariff landscapes, proactive collaboration between manufacturers, distributors, and regulatory authorities will remain essential. By prioritizing agility and strategic sourcing, stakeholders can safeguard operational continuity and maintain competitive positioning despite persistent trade uncertainties.

Unveiling critical segmentation insights by product type, technology, sample variation, application domain, end user, and distribution channels in the DBS card market

Insights into the dried blood spot collection card sector reveal that product type differentiation significantly influences user selection criteria. End users evaluating filter paper cards versus polymer coated cards weigh attributes such as analyte stability, sample homogeneity, and compatibility with downstream assays. Meanwhile, distinctions in technology manifest through the coexistence of standard DBS cards alongside advanced DBS cards engineered for high-throughput applications and enhanced biomarker recovery.

Sample type considerations further shape procurement strategies, as plasma spots, serum spots, and whole blood spots each present unique analytical challenges and opportunities. Applications span from clinical diagnostics and disease surveillance to forensic toxicology, newborn screening, and therapeutic drug monitoring. Within newborn screening, programs targeting congenital hypothyroidism, cystic fibrosis screening, and phenylketonuria rely heavily on card performance to ensure accurate early detection and timely intervention.

End user segmentation underscores varied operational imperatives across diagnostic laboratories, home care settings, hospitals & clinics, and research institutes. While laboratories demand high-capacity automation and standardized quality control, home care settings prioritize ease of use and patient compliance. Distribution channels extend from direct sales arrangements that foster closer supplier relationships to distributors & wholesalers offering broad market reach and logistical support. Collectively, these segmentation insights illuminate the multifaceted requirements driving innovation and market adoption.

Highlighting key regional dynamics and strategic growth drivers for dried blood spot collection cards across the Americas, Europe Middle East Africa and Asia Pacific

Regional dynamics in the dried blood spot collection card market reflect diverse healthcare infrastructures and regulatory frameworks. In the Americas, widespread adoption is fueled by robust diagnostic laboratory networks, strong reimbursement policies, and federal support for public health surveillance initiatives. Market participants in this region have capitalized on strategic partnerships to expand remote sampling programs and streamline sample transport across vast geographies.

Across Europe, Middle East & Africa, heterogeneous regulatory landscapes and varying levels of healthcare investment create both challenges and opportunities. While Western European nations emphasize stringent quality standards and integrated digital solutions, emerging economies in the Middle East & Africa are increasingly leveraging dried blood spot cards to enhance access to essential diagnostics in resource-limited settings. Collaborative efforts between local governments and international organizations are driving capacity building and standardization efforts throughout the region.

In the Asia-Pacific region, rapid urbanization, growing prevalence of chronic diseases, and rising demand for point-of-care testing underpin strong market momentum. Manufacturers have responded by establishing regional production facilities and forging distribution alliances to meet localized requirements. As investment in laboratory infrastructure intensifies, the Asia-Pacific landscape will continue to emerge as a key growth driver for dried blood spot collection card applications across clinical and research domains.

Examining leading industry participants driving innovation, partnership strategies, and competitive positioning in the dried blood spot collection card sector

The competitive landscape for dried blood spot collection cards is marked by both established life science corporations and specialized niche players. Leading entities have leveraged long-standing expertise in substrate technologies to introduce next-generation card formats that address critical performance parameters. These organizations often engage in strategic partnerships with assay developers and instrumentation providers to validate their products in diverse applications.

Concurrently, emerging companies are carving out differentiation through proprietary polymer formulations and digital integration capabilities. By focusing on targeted end-use segments-such as neonatal screening programs or forensic casework-they cultivate specialized offerings that underscore reliability and user-centric design. Partnerships with clinical research organizations and academic institutions further bolster credibility through peer-reviewed validation studies.

To maintain competitive advantage, market participants consistently invest in research and development, pursue regulatory certifications, and expand their geographic footprints. As the sector evolves, collaboration between card manufacturers, diagnostics firms, and healthcare providers will remain instrumental in driving adoption and unlocking new application frontiers.

Providing actionable strategic recommendations for industry leaders to capitalize on emerging opportunities and navigate evolving challenges in the DBS card landscape

To thrive in the dynamic dried blood spot collection card arena, industry leaders should prioritize material innovation by allocating resources to advanced polymer and substrate research that enhances analyte recovery under diverse environmental conditions. In tandem, the integration of digital tracking features will be essential for ensuring sample traceability, bolstering data integrity, and aligning with increasingly rigorous regulatory requirements.

Strategic sourcing strategies must be refined to mitigate supply chain disruptions. Establishing regional production hubs and diversifying supplier networks can reduce lead times and buffer against fluctuating trade policies. Moreover, cultivating collaborative relationships with diagnostic laboratories and healthcare providers will uncover tailored application opportunities, such as point-of-care screening initiatives and at-home testing programs.

Finally, embedding customer-centric service models-including comprehensive training modules, technical support, and consultative assay development-will strengthen brand loyalty and differentiate offerings. By adopting a holistic approach that merges technological advancement with operational agility and client collaboration, stakeholders can capitalize on emerging opportunities and maintain resilience amid evolving market dynamics.

Detailing the comprehensive research methodology, data acquisition techniques, and analytical frameworks underpinning this dried blood spot collection card study

This study employed a multi-tiered research methodology to ensure depth, accuracy, and relevance. The foundational layer comprised extensive secondary research, encompassing industry publications, regulatory guidelines, and peer-reviewed journals to establish the scope of material innovations, application domains, and competitive dynamics. This desk research informed the development of structured interview guides and survey instruments.

Primary research was conducted through in-depth interviews with senior executives, product development specialists, and quality assurance managers from leading card manufacturers, diagnostic laboratories, and research institutions. These conversations provided nuanced perspectives on technology adoption drivers, regulatory compliance challenges, and end-user requirements. Additional insights were gathered through site visits to manufacturing facilities and lab demonstrations, yielding real-world validation of performance claims.

Analytical frameworks, including SWOT and PESTEL analyses, were applied to synthesize qualitative and quantitative findings. Cross-verification techniques and triangulation ensured consistency and mitigated bias. The resulting dataset underpins a comprehensive understanding of current market dynamics, emerging trends, and strategic imperatives for key stakeholders in the dried blood spot collection card ecosystem.

Concluding insights summarizing the pivotal trends, market dynamics, and emerging imperatives shaping the future of dried blood spot collection cards

In summary, dried blood spot collection cards stand at the intersection of innovation and accessibility within modern diagnostics. Material advancements and digital integrations are redefining performance benchmarks, while regulatory harmonization efforts are enhancing quality assurance across global markets. Tariff-induced supply chain recalibrations have underscored the value of strategic sourcing and local production capabilities.

Segmentation analysis highlights the importance of tailoring solutions to distinct user needs, whether addressing plasma spots in high-throughput laboratories or enabling whole blood spot testing in decentralized settings. Regional insights reveal divergent growth trajectories, with the Americas leveraging established infrastructures, Europe, Middle East & Africa balancing standardization and resource expansion, and Asia-Pacific capitalizing on rapid healthcare investments.

Looking ahead, sustained collaboration between card manufacturers, diagnostics partners, and end users will be crucial for unlocking new application frontiers and driving adoption. By embracing innovation, reinforcing supply chain resilience, and deepening customer engagement, stakeholders can chart a path toward scalable and impactful diagnostic solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Dried Blood Spot Collection Cards Market, by Product Type

  • 8.1. Filter Paper Cards
  • 8.2. Polymer Coated Cards

9. Dried Blood Spot Collection Cards Market, by Technology

  • 9.1. Advanced DBS Cards
  • 9.2. Standard DBS Cards

10. Dried Blood Spot Collection Cards Market, by Sample Type

  • 10.1. Plasma Spots
  • 10.2. Serum Spots
  • 10.3. Whole Blood Spots

11. Dried Blood Spot Collection Cards Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Disease Surveillance
  • 11.3. Forensic Toxicology
  • 11.4. Newborn Screening
    • 11.4.1. Congenital Hypothyroidism
    • 11.4.2. Cystic Fibrosis Screening
    • 11.4.3. Phenylketonuria
  • 11.5. Therapeutic Drug Monitoring

12. Dried Blood Spot Collection Cards Market, by End User

  • 12.1. Diagnostic Laboratories
  • 12.2. Home Care Settings
  • 12.3. Hospitals & Clinics
  • 12.4. Research Institutes

13. Dried Blood Spot Collection Cards Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors & Wholesalers

14. Dried Blood Spot Collection Cards Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Dried Blood Spot Collection Cards Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Dried Blood Spot Collection Cards Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Dried Blood Spot Collection Cards Market

18. China Dried Blood Spot Collection Cards Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2024
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2024
  • 19.3. Product Portfolio Analysis, 2024
  • 19.4. Benchmarking Analysis, 2024
  • 19.5. ADVANTEC MFS, INC.
  • 19.6. Ahlstrom Oyj
  • 19.7. ARCHIMEDlife GmbH by amedes Holding GmbH
  • 19.8. BioIVT LLC
  • 19.9. Cambrian Biotech Pvt. Ltd.
  • 19.10. Capitainer AB
  • 19.11. CENTOGENE GmbH
  • 19.12. Chemie-Erzeugnisse und Adsorptionstechnik AG
  • 19.13. DBS System SA
  • 19.14. Eastern Business Forms, Inc
  • 19.15. F. Hoffmann-La Roche Ltd.
  • 19.16. Huachenyang (Shenzhen) Technology Co., Ltd
  • 19.17. Inotiv, Inc.
  • 19.18. Kala Scientific INC.
  • 19.19. Merck KGaA
  • 19.20. Monobind Inc.
  • 19.21. OmegaQuant Analytics, LLC
  • 19.22. QIAGEN N.V.
  • 19.23. RDA Spot Inc
  • 19.24. Salimetrics, LLC.
  • 19.25. Shimadzu Corporation
  • 19.26. Telimmune LLC
  • 19.27. Tianjin Geneally Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 2. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 14. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 2. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 3. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FILTER PAPER CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FILTER PAPER CARDS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FILTER PAPER CARDS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POLYMER COATED CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POLYMER COATED CARDS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY POLYMER COATED CARDS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ADVANCED DBS CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ADVANCED DBS CARDS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY ADVANCED DBS CARDS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STANDARD DBS CARDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STANDARD DBS CARDS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY STANDARD DBS CARDS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PLASMA SPOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PLASMA SPOTS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PLASMA SPOTS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SERUM SPOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SERUM SPOTS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SERUM SPOTS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY WHOLE BLOOD SPOTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY WHOLE BLOOD SPOTS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY WHOLE BLOOD SPOTS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE SURVEILLANCE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISEASE SURVEILLANCE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TOXICOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TOXICOLOGY, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY FORENSIC TOXICOLOGY, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CONGENITAL HYPOTHYROIDISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CONGENITAL HYPOTHYROIDISM, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CONGENITAL HYPOTHYROIDISM, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CYSTIC FIBROSIS SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CYSTIC FIBROSIS SCREENING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY CYSTIC FIBROSIS SCREENING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHENYLKETONURIA, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PHENYLKETONURIA, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTORS & WHOLESALERS, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 74. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 87. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. NORTH AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 95. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. LATIN AMERICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SUBREGION, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 114. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 119. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. MIDDLE EAST DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 122. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 127. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. AFRICA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY GROUP, 2018-2030 (USD MILLION)
  • TABLE 138. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 144. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. ASEAN DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 147. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 152. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. GCC DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPEAN UNION DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 163. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 168. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. BRICS DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 171. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 176. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. G7 DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 184. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. NATO DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. GLOBAL DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED STATES DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 196. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY NEWBORN SCREENING, 2018-2030 (USD MILLION)
  • TABLE 201. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. CHINA DRIED BLOOD SPOT COLLECTION CARDS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)